Limited-Time Offer: Enjoy 50% Savings! - Ends In 0d 00h 00m 00s Coupon code: 50OFF
Welcome to QA4Exam
Logo

- Trusted Worldwide Questions & Answers

SOCRA CCRP Dumps - Pass Certified Clinical Research Professional Exam in First Attempt 2026

The SOCRA CCRP exam, or Certified Clinical Research Professional exam, is part of the SOCRA CCRP Certification track. It is designed for professionals involved in clinical research who want to validate their knowledge and practical understanding of the field. This certification matters because it reflects competency across key stages of clinical research operations and supports professional credibility. Preparing well for the CCRP exam can help candidates approach the test with greater confidence and focus.

# Exam Topics Sub-Topics Approximate Weightage (%)
1 Research Study Start-Up Protocol review, site initiation, regulatory documentation, study activation 30%
2 Research Study Implementation Subject enrollment, data collection, source documentation, safety reporting 45%
3 Research Study Closure Closeout procedures, record reconciliation, final reporting, document archiving 25%

The SOCRA CCRP exam tests how well candidates understand the clinical research lifecycle, from study start-up through implementation and closure. It evaluates practical knowledge, process awareness, and the ability to apply concepts in real-world research settings. Candidates should be prepared for questions that measure both accuracy and judgment across core operational tasks.

How QA4Exam.com Helps You Pass

QA4Exam.com provides Exam PDF materials with actual questions and answers that help you study with a clear focus on the CCRP exam format. The Online Practice Test gives you a realistic exam simulation so you can build confidence before test day. You also get up-to-date questions and verified answers, which makes your preparation more efficient and reliable. In addition, practicing under timed conditions helps improve time management and reduces exam-day pressure. These resources are designed to support faster review and stronger readiness for the SOCRA CCRP exam.

FAQ

What is the SOCRA CCRP exam?

The SOCRA CCRP exam is the Certified Clinical Research Professional exam offered under the SOCRA CCRP Certification. It is intended for clinical research professionals who want to demonstrate their knowledge and skills in this area.

Who should take the CCRP exam?

The exam is suitable for professionals working in clinical research who want formal recognition of their expertise. It is especially useful for candidates involved in study start-up, implementation, and closure activities.

Is the SOCRA CCRP exam difficult?

The difficulty depends on your experience and preparation level. Candidates who understand the exam topics and practice with realistic questions usually feel more confident on test day.

Can I pass with only braindumps?

Braindumps alone are not the best approach. You should combine them with review and practice so you understand the concepts behind the answers and improve your overall readiness.

Do I need hands-on experience to pass CCRP?

Hands-on experience can help because the exam covers practical clinical research tasks. However, focused study with quality exam materials and practice tests can also strengthen your preparation.

Are QA4Exam.com dumps and practice test enough for first attempt success?

QA4Exam.com resources can be a strong part of your preparation because they include actual questions and answers, up-to-date content, and a practice test format. Using them consistently can improve accuracy, timing, and confidence for a first attempt.

What format do the QA4Exam.com CCRP materials use?

The materials are available as an Exam PDF and an Online Practice Test. This combination lets you study offline, review verified answers, and practice in a simulated exam environment.

The questions for CCRP were last updated on Jul 19, 2026.
  • Viewing page 1 out of 26 pages.
  • Viewing questions 1-5 out of 130 questions
Get All 130 Questions & Answers
Question No. 1

A physician with 20 years of experience is planning to be the site investigator for a multi-center, Phase I oncology clinical trial. In accordance with the ICH GCP Guideline, which of the following documents should the physician provide to the sponsor and the IRB/IEC?

Show Answer Hide Answer
Correct Answer: C

Investigators must provide evidence of qualifications to conduct the study.

ICH E6(R2) 4.1.1: ''The investigator should be qualified by education, training, and experience to assume responsibility for the proper conduct of the trial.''

ICH E6(R2) 8.2.10: Essential documents include the curriculum vitae (CV) or other documents evidencing investigator qualifications, submitted to both sponsor and IRB/IEC.

Proof of citizenship (A) and letters of recommendation (B) are irrelevant. A copy of a medical license (D) may be provided but is not specifically required by ICH. The CV is the universally required document.

Thus, the correct answer is C (Curriculum vitae).


ICH E6(R2), 4.1.1 (Investigator qualifications).

ICH E6(R2), 8.2.10 (Essential documents: CV).

Question No. 2

After the sponsor's auditor completes the final audit report for a Phase II trial with an investigational new drug, which of the following is responsible for providing the audit certificate to the clinical site?

Show Answer Hide Answer
Correct Answer: D

Audits are part of sponsor quality assurance to ensure trial compliance.

ICH E6(R2) 5.19.3: ''The sponsor's auditing procedures should include the provision of an audit certificate where required.''

ICH E6(R2) 8.2.20: Audit certificates are essential documents generated and retained by the sponsor.

IRBs (A), regulators (B), and DSMBs (C) are not responsible for audit documentation. Therefore, only the sponsor issues and maintains audit certificates, providing them to sites when appropriate.

Correct answer: D.


ICH E6(R2), 5.19.3.

ICH E6(R2), 8.2.20.

Question No. 3

A physician wants to conduct research using an approved/marketed cardiac stent for use in the carotid artery, which is not an indication for which the device is approved. In this case, the physician must obtain which of the following?

Show Answer Hide Answer
Correct Answer: C

When a physician investigates a medical device for a new use (off-label indication), FDA regulations classify this as a Significant Risk Device Study, requiring an Investigational Device Exemption (IDE) in addition to IRB approval.

21 CFR 812.20(a): ''A sponsor shall submit an application to FDA for an investigational device exemption (IDE) if the device is to be used in a clinical investigation to determine safety and effectiveness.''

21 CFR 812.2(b): Significant Risk device studies require both FDA and IRB approval before initiation.

An IND (B) applies to drugs and biologics, not devices. Manufacturer permission (A, D) is not a regulatory requirement, although collaboration may be necessary. OHRP approval is not applicable.

Thus, the correct answer is C (IRB/IEC approval and an FDA IDE).


21 CFR 812.20(a) (IDE submission requirements).

21 CFR 812.2(b) (Significant risk device studies).

Question No. 4

Which of the following statements about the FDA's authority to inspect IRB/IEC records is correct?

Show Answer Hide Answer
Correct Answer: B

The FDA has full regulatory authority to inspect IRB/IEC records.

21 CFR 56.115(b): ''The IRB shall permit representatives of the Food and Drug Administration to inspect and copy all records maintained... at reasonable times and in a reasonable manner.''

Thus, FDA may inspect and copy IRB/IEC records without requiring an affidavit or invitation. This ensures regulatory oversight and human subject protection.

Incorrect options:

(A) limits authority incorrectly.

(C) is false --- FDA explicitly regulates IRBs.

(D) is false --- FDA does not need IRB invitation.

Correct answer: B.


21 CFR 56.115(b).

Question No. 5

An investigator received an updated informed consent form (ICF) from the sponsor for a study closed to enrollment. Subjects are only in long-term follow-up. The change related to frequent radiation imaging at screening, with no change to drug safety profile. Who must the investigator notify first?

Show Answer Hide Answer
Correct Answer: C

21 CFR 56.109(a): IRBs must review all changes to informed consent before implementation.

ICH E6(R2) 4.8.2: If new information could affect willingness to continue, consent forms must be revised and approved by the IRB.

Even though screening is closed, the IRB/IEC must review the updated form before any subject re-consenting.


Unlock All Questions for SOCRA CCRP Exam

Full Exam Access, Actual Exam Questions, Validated Answers, Anytime Anywhere, No Download Limits, No Practice Limits

Get All 130 Questions & Answers